RxDoctor Payments Data

Jill Gadzinski, MD

Gynecologic Oncology · Royal Oak, MINPI 1427376854

Payments from drug & device makers

What this record shows

This record is dominated by education: $4,000 of the $4,764 with a category attached, or 84.0%. Intuitive Surgical accounts for 88.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $4,150 and has fallen 89.1% since, to $451 in 2025.

$4,764in general payments, 2019–2025

Across 12 payments — averaging $397.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • AbbVie$255
  • Merck$132
  • Conmed Corporation$48
  • GSK$45
  • Boston Scientific$35
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$76416%
  • Education$4,00084%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical3$4,237
AbbVie2$255
Merck2$132
Conmed Corporation1$48
GSK1$45
Boston Scientific2$35
Seagen Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,764 in reported general payments places this provider in the 75th percentile of 43 gynecologic oncology providers in Michigan.

See all gynecologic oncology providers in Michigan

Medicare billing

Part B allowed, 2024
$68,852
Medicare patients
172
Services billed
362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone20$526
Prochlorperazine Maleate23$245
Lidocaine-PrilocaineLidocaine/Prilocaine17$170
Ondansetron Hcl15$69
Omeprazole15$59

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Royal Oak

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →